TSHA |
Taysha Gene Therapies, Inc. |
May 29, 2024 |
2 |
$0 |
4 |
May 31, 2024 |
Director |
NTLA |
Intellia Therapeutics, Inc. |
Mar 1, 2024 |
2 |
$0 |
4 |
Mar 5, 2024 |
EVP, Chief Scientific Officer |
NTLA |
Intellia Therapeutics, Inc. |
Jan 8, 2024 |
2 |
-$65.7K |
4 |
Jan 10, 2024 |
EVP, Chief Scientific Officer |
NTLA |
Intellia Therapeutics, Inc. |
Jan 3, 2024 |
1 |
-$163K |
4 |
Jan 5, 2024 |
EVP, Chief Scientific Officer |
NTLA |
Intellia Therapeutics, Inc. |
Jan 1, 2024 |
2 |
$0 |
4 |
Jan 3, 2024 |
EVP, Chief Scientific Officer |
TSHA |
Taysha Gene Therapies, Inc. |
Jun 22, 2023 |
1 |
$0 |
4 |
Jun 26, 2023 |
Director |
NTLA |
Intellia Therapeutics, Inc. |
Mar 1, 2023 |
2 |
$0 |
4 |
Mar 3, 2023 |
EVP, Chief Scientific Officer |
NTLA |
Intellia Therapeutics, Inc. |
Jan 4, 2023 |
3 |
-$183K |
4 |
Jan 6, 2023 |
EVP, Chief Scientific Officer |
NTLA |
Intellia Therapeutics, Inc. |
Jan 1, 2023 |
2 |
$0 |
4 |
Jan 4, 2023 |
EVP, Chief Scientific Officer |
TSHA |
Taysha Gene Therapies, Inc. |
Jun 17, 2022 |
1 |
$0 |
4 |
Jun 22, 2022 |
Director |
NTLA |
Intellia Therapeutics, Inc. |
Mar 1, 2022 |
1 |
$0 |
4/A |
Mar 4, 2022 |
EVP, Chief Scientific Officer |
NTLA |
Intellia Therapeutics, Inc. |
Jan 1, 2022 |
5 |
-$129K |
4 |
Mar 3, 2022 |
EVP, Chief Scientific Officer |
NTLA |
Intellia Therapeutics, Inc. |
Aug 30, 2021 |
13 |
-$13.7M |
4 |
Sep 1, 2021 |
EVP, Chief Scientific Officer |
NTLA |
Intellia Therapeutics, Inc. |
Aug 4, 2021 |
9 |
-$3.25M |
4 |
Aug 6, 2021 |
EVP, Chief Scientific Officer |
TSHA |
Taysha Gene Therapies, Inc. |
Jun 17, 2021 |
1 |
$0 |
4 |
Jun 21, 2021 |
Director |